Related Experiment Video
Updated: Jul 18, 2025

Pharmacologic Induction of Epidermal Melanin and Protection Against Sunburn in a Humanized Mouse Model
Published on: September 7, 2013
Alpha-melanocyte stimulating hormone (α-MSH): biology, clinical relevance and implication in melanoma
Luigi Dall'Olmo1,2, Nicole Papa3, Nicoletta Concetta Surdo4,5
1Department of Surgical Oncological and Gastroenterological Sciences, Padua University, Via Giustiniani 2, 35128, Padua, Italy. luigi.dallolmo@unipd.it.
Abstract:
Alpha-melanocyte stimulating hormone (α-MSH) and its receptor, melanocortin 1 receptor (MC1R), have been proposed as potential target for anti-cancer strategies in melanoma research, due to their tissue specific expression and involvement in melanocyte homeostasis. However, their role in prevention and treatment of melanoma is still debated and controversial. Although a large body of evidence supports α-MSH in preventing melanoma development, some preclinical findings suggest that the α-MSH downstream signalling may promote immune escape and cancer resistance to therapy. Additionally, in metastatic melanoma both MC1R and α-MSH have been reported to be overexpressed at levels much higher than normal cells. Furthermore, targeted therapy (e.g. BRAF inhibition in BRAFV600E mutant tumours) has been shown to enhance this phenomenon. Collectively, these data suggest that targeting MC1R could serve as an approach in the treatment of metastatic melanoma. In this review, we explore the molecular biology of α-MSH with particular emphasis into its tumor-related properties, whilst elaborating the experimental evidence currently available regarding the interplay between α-MSH/MC1R axis, melanoma and antitumor strategies.
Insights
Alpha-melanocyte stimulating hormone (α-MSH) and its receptor (MC1R) show complex roles in melanoma. While potentially protective, their signaling may also drive immune escape and resistance, suggesting MC1R as a therapeutic target in metastatic melanoma.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- The alpha-melanocyte stimulating hormone (α-MSH) and melanocortin 1 receptor (MC1R) axis is implicated in melanocyte biology.
- Their role in melanoma development, prevention, and treatment remains controversial.
- MC1R and α-MSH expression is altered in melanoma, particularly in metastatic stages.
Purpose of the Study:
- To review the molecular biology of α-MSH.
- To explore the tumor-related properties of α-MSH and MC1R in melanoma.
- To analyze the interplay between the α-MSH/MC1R axis and melanoma antitumor strategies.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of molecular mechanisms of α-MSH/MC1R signaling in melanoma.
- Examination of evidence regarding targeted therapies and immune response.
Main Results:
- Evidence suggests α-MSH can prevent melanoma development.
- Conversely, α-MSH signaling may promote immune escape and therapy resistance.
- Overexpression of MC1R and α-MSH is observed in metastatic melanoma, potentially enhanced by targeted therapies like BRAF inhibition.
Conclusions:
- The α-MSH/MC1R axis presents a dual role in melanoma.
- Targeting MC1R may offer a therapeutic strategy for metastatic melanoma.
- Further research is needed to elucidate the complex interactions and optimize therapeutic approaches.
Related Concept Videos
Mitogens and the Cell Cycle
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Major Hormones and Their Functions
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
Abnormal Proliferation
Mesenchymal Stem Cells
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

